Study S001245

Liraglutide's Effect on Weight Loss in Patients After Secondary Bariatric Surgery ; a Randomized Double-blind Controlled Study.

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

Included trial: extracted data ClinicalTrials.gov record

Registration

Registration: NCT05285397
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Masking: DOUBLE
Status: UNKNOWN
Enrollment: 60
Start: 2022-03-10
Primary completion: 2022-09
Lead sponsor: General Committee of Teaching Hospitals and Institutes, Egypt
Conditions: Morbid Obesity
Interventions: DRUG:Liraglutide Pen Injector [Saxenda]
Results posted: FALSE
Individual participant data sharing: UNDECIDED

Registered primary outcomes

Percentage Total weight loss [6 months]
Percentage Excess body weight loss [6 months]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0024162	Liraglutide Augments Weight Loss After Laparoscopic Sleeve Gastrectomy: a Randomised, Double-Blind, Placebo-Control Study. Thakur U, Obesity surgery	2021	Randomized trial	PMID 32656729 DOI	registry reference BACKGROUND:32656729